Zai Lab (ZLAB) Treasury Shares (2021 - 2026)
Zai Lab (ZLAB) posted Treasury Shares of $31.3 million for Q1 2026, up 7.81% sequentially from $29.1 million in Q4 2025, and up 50.32% YoY from $20.8 million in Q1 2025.
Zai Lab (ZLAB) Treasury Shares (2021 - 2026) Analysis & Trends
Zai Lab has reported Treasury Shares for 6 years, with the latest figure at $31.3 million in Q1 2026.
- Quarterly Treasury Shares rose 50.32% year-over-year to $31.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.3 million (up 50.32% YoY) and the FY2025 annual result came in at $29.1 million, up 39.44% from the prior year.
- Treasury Shares improved to $31.3 million in Q1 2026 per ZLAB's latest filing, from $29.1 million in the prior quarter.
- Over five years, Treasury Shares peaked at $8.6 million in Q1 2026 and troughed at $398080.0 in Q1 2022.
- A 4-year average of $4.6 million and a median of $4.9 million in 2023 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2024: Treasury Shares surged 1104.44% in 2022, then changed 0.0% in 2024.
- Over 5 years, Treasury Shares stood at $11.9 million in 2022, then jumped by 75.74% to $20.8 million in 2023, then changed by 0.0% to $20.8 million in 2024, then surged by 39.44% to $29.1 million in 2025, then advanced by 7.81% to $31.3 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $31.3 million, $29.1 million, and $29.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | 33.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.52 Mn |
| Jun 30, 2026 | 9.78 Mn |
| Jun 30, 2026 | 9.78 Mn |
| Jun 30, 2026 | 33.52 Mn |
| Mar 31, 2026 | 31.32 Mn |
| Mar 31, 2026 | 31.32 Mn |
| Mar 31, 2026 | 8.60 Mn |
| Mar 31, 2026 | 8.60 Mn |
| Dec 31, 2025 | 7.43 Mn |
| Dec 31, 2025 | 7.43 Mn |
| Dec 31, 2025 | 29.05 Mn |
| Dec 31, 2025 | 29.05 Mn |
| Sep 30, 2025 | 7.43 Mn |
| Sep 30, 2025 | 29.05 Mn |
| Sep 30, 2025 | 29.05 Mn |
| Sep 30, 2025 | 7.43 Mn |
| Jun 30, 2025 | 4.92 Mn |
| Jun 30, 2025 | 20.86 Mn |
| Jun 30, 2025 | 20.86 Mn |
| Jun 30, 2025 | 4.92 Mn |